Related Experiment Video
Updated: Jun 25, 2025

05:44
Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins
Published on: May 24, 2024
617
Venous Sinus Stent to Treat Paralysis
1Department of Neurological Surgery, Houston Methodist Hospital, 6560 Fannin Street, Suite 944, Houston, TX 77030, USA.
Neurosurgery Clinics of North America
|May 23, 2024
Summary
The Stentrode device offers a novel transvenous treatment for paralysis, enabling patients to perform daily activities. Early trials show promising safety and functionality for this emerging neural interface technology.
Area of Science:
- Biomedical Engineering
- Neuroscience
- Medical Devices
Background:
- Transvenous treatment for paralysis is an emerging medical concept.
- The Stentrode is a novel electrode-on-stent device designed for implantation in the superior sagittal sinus.
Purpose of the Study:
- To evaluate the safety and efficacy of the Stentrode device for treating paralysis.
- To assess the Stentrode's capability in detecting neural signals and facilitating daily activities for patients.
Main Methods:
- Animal studies in sheep were conducted to assess implant safety and neural signal detection accuracy.
- Early human trials were performed to evaluate the device's safety and functional use in patients with paralysis.
Main Results:
- Animal studies demonstrated the safety and accuracy of the Stentrode for neural signal detection.
- Human trials confirmed the device's safety and showed its utility in enabling patients to perform daily tasks like texting and email.
Conclusions:
- The Stentrode device shows promise as a transvenous treatment for paralysis.
- Further research is necessary to fully understand the capabilities and limitations of this emerging neural interface technology.

